Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2001 Jul;85(1):F33–F35. doi: 10.1136/fn.85.1.F33

Factors affecting the incidence of chronic lung disease of prematurity in 1987, 1992, and 1997

B Manktelow, E Draper, S Annamalai, D Field
PMCID: PMC1721286  PMID: 11420319

Abstract

OBJECTIVE—To determine changes in the incidence of chronic lung disease of prematurity between 1987, 1992, and 1997.
METHODS—Observational study based on data derived from a geographically defined population: Trent Health Region, United Kingdom. Three time periods were compared: 1 February 1987 to 31 January 1988(referred to as 1987); 1 April 1992 to 31 March 1993 (referred to as 1992); 1997. All infants of ⩽ 32 completed weeks gestation born to Trent resident mothers within the study periods and admitted to a neonatal unit were included. Rates of chronic lung disease were determined using two definitions: (a) infants who remained dependent on active respiratory support or increased oxygen at 28 days of age; (b) infants who remained dependent on active respiratory support or increased oxygen at a corrected age of 36 weeks gestation.
RESULTS—Between 1987 and 1992 there was a fall in the birth rate, but a significant increase was noted in the number of babies of ⩽ 32 weeks gestation admitted to a neonatal unit. There was no significant change in survival when the two groups of infants were directly compared. However, mean gestation and birth weight fell. Adjusting for this change showed a significant improvement in survival (28 day survival: odds ratio (OR) = 1.69; 95% confidence interval (95% CI) = 1.23 to 2.33. Survival to 36 week corrected gestation: OR = 1.45; 95% CI = 1.06 to 1.98). These changes were accompanied by a large increase in the incidence of chronic lung disease even after allowing for the change in population characteristics (28 day definition: OR = 2.20; 95% CI = 1.47 to 3.30. 36 week definition: OR = 3.04; 95% CI = 1.91 to 4.83). Between 1992 and 1997 a different pattern emerged. There was a further increase in the number of babies admitted for neonatal care at ⩽ 32 weeks gestation despite a continuing fall in overall birth rate. Survival, using both raw data and data corrected for changes in gestation and birth weight, improved significantly in 1997 (adjusted data: 28 day survival: OR = 1.72 (95% CI = 1.22 to 2.38); survival to 36 week corrected gestation: OR = 1.90 (95% CI = 1.36 to 2.64)). Rates of chronic lung disease showed no significant change between 1992 and 1997 despite improved survival (adjusted data: 28 day definition: OR = 0.72 (95% CI = 0.50 to 1.03); 36 week definition: OR = 0.88 (95% CI = 0.61 to 1.26).
CONCLUSIONS—Current high rates of chronic lung disease are the result of policies to offer neonatal intensive care more widely to the most immature infants. Recent improvements in survival have been achieved without further increases in the risk of infants developing chronic lung disease.



Full Text

The Full Text of this article is available as a PDF (109.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avery M. E., Tooley W. H., Keller J. B., Hurd S. S., Bryan M. H., Cotton R. B., Epstein M. F., Fitzhardinge P. M., Hansen C. B., Hansen T. N. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics. 1987 Jan;79(1):26–30. [PubMed] [Google Scholar]
  2. Ballard P. L., Ballard R. A. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol. 1995 Jul;173(1):254–262. doi: 10.1016/0002-9378(95)90210-4. [DOI] [PubMed] [Google Scholar]
  3. Beeby P., Chan D., Henderson-Smart D. Improved outcomes following the introduction of surfactant to an Australian neonatal unit. J Paediatr Child Health. 1996 Jun;32(3):257–260. doi: 10.1111/j.1440-1754.1996.tb01566.x. [DOI] [PubMed] [Google Scholar]
  4. Cassell G. H., Waites K. B., Crouse D. T., Rudd P. T., Canupp K. C., Stagno S., Cutter G. R. Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants. Lancet. 1988 Jul 30;2(8605):240–245. doi: 10.1016/s0140-6736(88)92536-6. [DOI] [PubMed] [Google Scholar]
  5. Fanaroff A. A., Wright L. L., Stevenson D. K., Shankaran S., Donovan E. F., Ehrenkranz R. A., Younes N., Korones S. B., Stoll B. J., Tyson J. E. Very-low-birth-weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, May 1991 through December 1992. Am J Obstet Gynecol. 1995 Nov;173(5):1423–1431. doi: 10.1016/0002-9378(95)90628-2. [DOI] [PubMed] [Google Scholar]
  6. Field D., Draper E. S. Survival and place of delivery following preterm birth: 1994-96. Arch Dis Child Fetal Neonatal Ed. 1999 Mar;80(2):F111–F114. doi: 10.1136/fn.80.2.f111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hack M., Fanaroff A. A. Outcomes of children of extremely low birthweight and gestational age in the 1990's. Early Hum Dev. 1999 Jan;53(3):193–218. doi: 10.1016/s0378-3782(98)00052-8. [DOI] [PubMed] [Google Scholar]
  8. Jacobsen T., Grønvall J., Petersen S., Andersen G. E. "Minitouch" treatment of very low-birth-weight infants. Acta Paediatr. 1993 Nov;82(11):934–938. doi: 10.1111/j.1651-2227.1993.tb12603.x. [DOI] [PubMed] [Google Scholar]
  9. Kamper J., Wulff K., Larsen C., Lindequist S. Early treatment with nasal continuous positive airway pressure in very low-birth-weight infants. Acta Paediatr. 1993 Feb;82(2):193–197. doi: 10.1111/j.1651-2227.1993.tb12637.x. [DOI] [PubMed] [Google Scholar]
  10. Kraybill E. N., Runyan D. K., Bose C. L., Khan J. H. Risk factors for chronic lung disease in infants with birth weights of 751 to 1000 grams. J Pediatr. 1989 Jul;115(1):115–120. doi: 10.1016/s0022-3476(89)80345-2. [DOI] [PubMed] [Google Scholar]
  11. Northway W. H., Jr, Rosan R. C., Porter D. Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967 Feb 16;276(7):357–368. doi: 10.1056/NEJM196702162760701. [DOI] [PubMed] [Google Scholar]
  12. Shennan A. T., Dunn M. S., Ohlsson A., Lennox K., Hoskins E. M. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988 Oct;82(4):527–532. [PubMed] [Google Scholar]
  13. Todd D. A., Jana A., John E. Chronic oxygen dependency in infants born at 24-32 weeks' gestation: the role of antenatal and neonatal factors. J Paediatr Child Health. 1997 Oct;33(5):402–407. doi: 10.1111/j.1440-1754.1997.tb01629.x. [DOI] [PubMed] [Google Scholar]
  14. Yoon B. H., Romero R., Jun J. K., Park K. H., Park J. D., Ghezzi F., Kim B. I. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 1997 Oct;177(4):825–830. doi: 10.1016/s0002-9378(97)70276-x. [DOI] [PubMed] [Google Scholar]
  15. Yoon B. H., Romero R., Kim K. S., Park J. S., Ki S. H., Kim B. I., Jun J. K. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 1999 Oct;181(4):773–779. doi: 10.1016/s0002-9378(99)70299-1. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES